Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ: MEDP )

290.54 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49
Open 290.54
Bid (Size) 282.00 (3)
Ask (Size) 296.43 (1)
Prev. Close 290.54
Today's Range 290.54 - 290.54
52wk Range 250.05 - 459.77
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
West Pharmaceutical Services Earnings: What To Look For From WST
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting results tomorrow before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Wall Street Bounces Back As Traders Shake Off Powell Jabs
Stocks are higher this afternoon, with all three major indexes bouncing back from Monday’s steep selloff. 
Via Talk Markets
Topics Stocks / Equities

Performance

YTD
-13.21%
-13.21%
1 Month
-12.11%
-12.11%
3 Month
-15.83%
-15.83%
6 Month
-11.98%
-11.98%
1 Year
-28.64%
-28.64%

More News

Read More
Why Medpace (MEDP) Stock Is Trading Lower Today
Via StockStory
Medpace Hits 17-Month Low After Bookings Miss Leaves Investors Mystified
Via Investor's Business Daily
Insights into Medpace Hldgs's Upcoming Earnings
Via Benzinga
Thermo Fisher (TMO) Reports Earnings Tomorrow: What To Expect
Via StockStory
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Medpace Holdings Reports Q1 Earnings, Shares Move Lower
Via Benzinga
Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock Drops
Via StockStory
Medpace Holdings, Inc. Reports First Quarter 2025 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For April 21, 2025
Via Benzinga
Medpace (MEDP) Q1 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
What 5 Analyst Ratings Have To Say About Medpace Hldgs
Via Benzinga
1 Spectacular Growth Stock Down 34% to Buy Hand Over Fist
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
3 Market-Beating Stocks with Solid Fundamentals
Via StockStory
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
This Kraft Heinz Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Via StockStory
Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025
From Medpace Holdings, Inc.
Via Business Wire
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)
Via StockStory
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
Via StockStory
2 Reasons to Watch MEDP and 1 to Stay Cautious
Via StockStory
Topics Stocks
Exposures US Equities
Why Medpace (MEDP) Shares Are Trading Lower Today
Via StockStory
Harmonic Issues Weak Guidance, Joins Fluence Energy, Amkor Technology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.